Buy, hold, sell: BHP, CSL, and Woodside shares

Let's see if analysts are bullish or bearish on these giants.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a lot of blue-chip ASX 200 shares to pick from on the Australian share market.

But not all are necessarily buys right now.

So, to narrow things down, let's see what analysts are saying about three of the most popular shares on the ASX 200 index. Here's what you need to know:

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.

Image source: Getty Images

BHP Group Ltd (ASX: BHP)

BHP is the world's largest mining company and a major producer of commodities such as iron ore, copper, and metallurgical coal.

One positive currently working in its favour is the strength in copper prices. Copper is widely viewed as one of the most important commodities for electrification, renewable energy infrastructure, and electric vehicles. With demand expected to rise strongly over the coming decade, BHP's significant exposure to copper could become an increasingly valuable part of its portfolio.

But does this make BHP shares a buy?

Morgan Stanley has an overweight rating on the mining giant with a $56.00 price target. Meanwhile, Ord Minnett has an accumulate rating with a $54.00 price target. This compares favourably to the current BHP share price of $49.39.

CSL Ltd (ASX: CSL)

CSL is one of Australia's largest healthcare companies and a global leader in plasma therapies, vaccines, and biotechnology products.

Unlike some other ASX heavyweights, CSL has not enjoyed much positive momentum recently. Its shares have come under significant pressure and are trading well below their historical highs, which has left the company looking relatively cheap compared to its long-term valuation.

Is this an opportunity to buy a high-quality healthcare business with global operations, a large research pipeline, and strong positions in specialised treatment markets?

Despite its struggles, brokers remain positive on CSL and see value in its shares. Morgans has a buy rating on the healthcare giant with a $241.34 price target, while UBS also has a buy rating and a $235.00 price target. This compares to the current CSL share price of $139.86.

Woodside Energy Group Ltd (ASX: WDS)

Woodside is Australia's largest oil and gas producer and generates the bulk of its earnings from global energy markets.

One of the major positives currently supporting the company is the strength in oil prices, which are trading above US$100 per barrel due to the war in the Middle East. Higher oil prices typically translate into stronger cash flow for energy producers, which can support dividends and investment in new projects.

Does this make Woodside shares a buy?

Well, due to recent share price strength, brokers are largely on the fence with this one. UBS currently has a neutral (hold) rating on the company with a $28.10 price target, while Macquarie also has a neutral rating with a $30.00 price target. This compares to the current Woodside share price of $31.51.

Motley Fool contributor James Mickleboro has positions in CSL and Woodside Energy Group Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended BHP Group and CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Person with thumbs down and a red sad face poster covering their face.
Broker Notes

6 ASX 200 shares downgraded by the experts this week

Brokers have reduced their ratings on six ASX 200 shares, including PLS Group and Westpac this week.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

Should you buy Wesfarmers shares amid rising profits and revenues?

A leading analyst offers his outlook for Wesfarmers shares.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Buy, hold, sell: Evolution Mining, Netwealth, and Nufarm shares

What is Morgans saying about these popular shares? Let's dig deeper into things.

Read more »

Health professional looking at a laptop.
Broker Notes

Is the Telix share price heading to $19? This broker thinks it is

Bell Potter remains bullish on this name. Here's what it is saying.

Read more »

Happy man working on his laptop.
Broker Notes

Broker says this ASX 200 stock can deliver a 20% return

Bell Potter is bullish on this fintech stock. Let's see what is saying about this one.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

ASX 200 shares with renewed buy ratings this week

Brokers have signalled ongoing confidence in Zip, ANZ, Coles, and several other ASX 200 shares.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

4 ASX 200 shares newly upgraded this week

As the Iran war and fuel crisis continues, some ASX 200 shares have attracted upgrades from the experts.

Read more »